Trending

Mitsubishi Tanabe

Mitsubishi Tanabe pulls ALS drug from EMA assessment

Mitsubishi Tanabe pulls ALS drug from EMA assessment

Mitsubishi Tanabe Pharma has withdrawn its EU application for ALS drug Radicava (edaravone), citing ‘unwarranted’ additional data requirements

X

Mitsubishi Tanabe pulls ALS drug from EMA assessment

https://pharmaphorum.com/news/mitsubishi-tanabe-pulls-als-drug-from-ema-assessment/

FDA approves first ALS treatment for two decades

FDA approves first ALS treatment for two decades

FDA asked Mitsubishi to file Radicava following approval in Japan.

X

FDA approves first ALS treatment for two decades

https://pharmaphorum.com/news/fda/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com